Jean‐Charles Ahomadegbe

P73 functionally replaces p53 in Adriamycin‐treated, p53‐deficient breast cancer cells

Muriel Vayssade, Hédi Haddada, Laetitia Faridoni‐Laurens et al. · International Journal of Cancer · 2005 · 91 citations

Medicine, Cancer Biology, Oncology +11

Cisplatin-induced apoptosis andp53 gene status in a cisplatin-resistant human ovarian carcinoma cell line

Anne Fajao, Jacqueline Da Silva, Jean‐Charles Ahomadegbe et al. · International Journal of Cancer · 1996 · 57 citations

Medicine, Molecular Biology, Oncology +17

No evidence of somatic FGFR3 mutation in various types of carcinoma

Mehdi Karoui, Hélène Hofmann‐Radvanyi, U. Zimmermann et al. · Oncogene · 2001 · 45 citations

Medicine, Genetics, Oncology +14

c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients

G Riou, Marie‐Christine Mathieu, Michel Barrois et al. · International Journal of Cancer · 2001 · 44 citations

Life Sciences, Cell Biology, Oncology +17

P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?

Laetitia Faridoni‐Laurens, Jacques Bosq, François Janot et al. · Oncogene · 2001 · 44 citations · Full text

Medicine, Molecular Genetics, Oncology +6